Keystone Bio is a biotechnology firm that focuses on developing bio-therapeutic-drugs for alzheimer disease treatment. Keystone Bio was founded in 2018. Keystone Bio's headquarters is located in St. Louis, Missouri, USA 63110.
Keystone Bio's CEO, Dan...
Keystone Bio's CEO, Daniel L. Sindelar, currently has an approval
rating of 90%. Keystone Bio's primary competitors are
There are no competitors identified for Keystone Bio
There have been no acquisitions found related to Keystone Bio
Recent investment data cannot be found related to Keystone Bio